Presenting Companies Announced for 2007 Mid-Atlantic Bio Conference.Fifteen Companies from Four Mid-Atlantic States Mid-At·lan·tic States See Middle Atlantic States. Noun 1. Mid-Atlantic states - a region of the eastern United States comprising New York and New Jersey and Pennsylvania and Delaware and Maryland U.S.A. Represent Biotechnology, Biopharmaceutical Drug Development and Discovery, Devices Research, and Vaccine Sectors BETHESDA, Md. -- Fifteen companies have been selected to present before an audience of venture capitalists Venture Capitalist An investor who provides capital to either start-up ventures or support small companies who wish to expand but do not have access to public funding. Notes: Venture capitalists usually expect higher returns for the additional risks taken. and industry professionals at 2007 Mid-Atlantic Bio, held October 24-26th at the Bethesda North Marriott and Conference Center. Dedicated to promoting the growth of biotechnology in the Mid-Atlantic region, the conference is collectively sponsored by the Mid-Atlantic's most influential bioscience and investor associations, the Mid-Atlantic Venture Association (MAVA MAVA Mid-Atlantic Venture Association MAVA Minnesota Association for Volunteer Administration MAVA Martin Van Buren National Historic Site (US National Park Service) MAVA Massachusetts Association of Vocational Administrators ), MdBio/Tech Council of Maryland and the Virginia Biotechnology Association The Virginia Biotechnology Association (VaBIO) is the statewide trade group that promotes the scientific and economic impact of the biotechnology industry in the Commonwealth of Virginia. (VaBIO). The majority of companies selected are from the host states of Maryland and Virginia, with others coming from additional leading biotech bi·o·tech n. Informal Biotechnology. biotech Noun short for biotechnology Noun 1. states in the mid-Atlantic - Pennsylvania and New Jersey. Selected in a competitive process, this year's companies represent a cross-section of industry sectors, with most coming from the biotechnology and biopharmaceutical sector and the remainder focused on drug development and discovery, devices, and vaccines. The companies, at various stages of development, range from seed and early stages to later stage growth. "Our goal was to select some of the most fundable healthcare investment opportunities in the market and we are proud that our rigorous selection process has identified these 15 quality presenting companies for our 2007 Mid-Atlantic Bio Conference," said Julia Spicer, Executive Director of MAVA and Host Committee Member. "With the leadership of Amita Shukla, NEA NEA abbr. 1. National Education Association 2. National Endowment for the Arts NEA (US) n abbr (= National Education Association) → Verband für das Erziehungswesen and Sinclair Dunlop, MASA ma·sa n. Dough made of dried corn that has been soaked in limewater then rinsed and ground, used especially in tortillas and tamales. [American Spanish, from Spanish, dough Life Science Ventures, coupled with the committee of investors that are working to produce this event, we are presenting a line-up of companies from a cross-section of sectors and various stages of development that will add to the incredibly strong programming already scheduled for this year's 2007 Mid-Atlantic Bio." The companies selected to present at 2007 Mid-Atlantic Bio are: * Alba Therapeutics therapeutics Treatment and care to combat disease or alleviate pain or injury. Its tools include drugs, surgery, radiation therapy, mechanical devices, diet, and psychiatry. Corporation (Baltimore, MD) * CoGenesys, Inc. (Rockville, MD) * Diffusion Pharmaceuticals LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control (Charlottesville, VA) * Elusys Therapeutics, Inc. (Pine Brook, NJ) * Envisionier Medical Technologies, Inc. (Rockville, MD) * GlycoMimetics, Inc. (Gaithersburg, MD) * Immune Control Inc. (West Conshohocken, PA) * Innovative Biosensors, Inc. (Rockville, MD) * Intrexon Corporation (Blacksburg, VA) * Neotropix Inc (Malvern, PA) * Nucleonics nucleonics the study of nucleons or of atomic nuclei and their reactions; nuclear physics. , Inc. (Horsham, PA) * Panacea Some antidote or remedy that completely solves a problem. Most so-called panaceas in this industry, if they survive at all, wind up sitting alongside and working with the products they were supposed to replace. Pharmaceuticals, Inc. (Gaithersburg, MD) * Sequoia Pharmaceuticals (Gaithersburg, MD) * SMART Biosciences (Philadelphia, PA) * VaxInnate (Cranbury, NJ) As part of the 2007 Mid-Atlantic Bio program, executives from presenting companies are participating in several pre-conference programs, including a networking event and half-day boot camp Software from Apple that enables an Intel x86-based Macintosh to host the Windows XP operating system. Boot Camp is used to divide the hard disk into Windows and Mac partitions, to install the necessary drivers and to create a dual boot environment. session to help prepare for the formal presentations before investors and industry attendees. About Mid-Atlantic Bio Mid-Atlantic Bio is the only regional event to combine components of an industry convention and investor conference under one roof. Co-hosted by MdBio/Tech Council of Maryland, the Mid-Atlantic Venture Association (MAVA), and the Virginia Biotechnology Association (VaBIO), the initiative benefits from broad regional support, including the investor and greater business communities, academic institutions, government agencies, and partnered regional associations. The event aims to bring together a critical mass of public and private stakeholders Stakeholders All parties that have an interest, financial or otherwise, in a firm-stockholders, creditors, bondholders, employees, customers, management, the community, and the government. , including biotechnology and pharmaceutical senior executives, scientists and researchers, academia, policy makers, legislators, and venture capitalists to provide a premiere Mid-Atlantic networking and business development forum, leverage the region's world-renowned R&D resources and opportunities, and favorably position the region's biotechnology industry in terms of its collective strengths, resources and competencies among key constituencies. For more on the Mid-Atlantic Bio Conference, complete program agenda and speaker information, as well as registration information, please visit www.MidAtlanticBio.org. About MdBio/Tech Council of Maryland MdBio/Tech Council of Maryland is a private non-profit trade association with a mission to promote the growth and quality of the life sciences and technology communities in Maryland and the region. For more information, please visit www.techcouncilmd.com. About MAVA Founded in 1986, MAVA represents the collective interests of venture capitalists investing in the mid-Atlantic, including more than 500+ venture professionals, at 125 firms, with more than $90 Billion in capital under management. For more information, please visit www.mava.org. About VaBIO VaBIO, the Virginia Biotechnology Association, is the 200-member statewide trade group that promotes the considerable scientific and economic impact of the life sciences industry in the Commonwealth of Virginia. For more information, visit www.vabio.org. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion